MedTrace Logo

Green Tea Attenuates Pressure Reduction Induced by a Session of Physical Exercise

NCT02578927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-10-19

No results posted yet for this study

Summary

The objective is to investigate whether the ingestion of green tea prior to physical exercise improvement post-exercise hypotension (PEH). Double-blind, randomized, placebo study. Fifteen hypertensive (53±4.5 years) performed three procedures: green tea+exercise (GT+Ex), placebo+exercise (PL+Ex), green tea without exercise (GT). Thirty minutes after ingesting 2g of green tea or placebo, they performed treadmill walking (60 minutes), 60 to 85% of maximum heart rate intensity in procedures with exercises. BP was measured at rest and at every 10 minutes after exercise (60 minutes). Blood samples were taken before the ingestion of green tea or placebo and immediately after exercise to determine Malondialdehyde (MDA) and Nitrite (NO) dosages. Reduction of systolic BP compared with the rest, during PL+Ex recovery procedure.

Conditions

Interventions

DIETARY_SUPPLEMENT

GT+Ex

In this session the volunteers ingested capsules with 2g of powder green tea before exercise

DIETARY_SUPPLEMENT

PL+Ex

In this session the volunteers ingested capsules with 2g of placebo before exercise

DIETARY_SUPPLEMENT

Green Tea

In this investigation the volunteers ingested capsules with 2g of powder green tea before the rest similar to the exercise time

Sponsors & Collaborators

  • Federal University of Paraíba

    lead OTHER

Principal Investigators

  • Manoel Miranda Neto, graduation · Federal University of Paraíba

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02578927 on ClinicalTrials.gov